Back to Search Start Over

Zoonotic Brazilian Vaccinia virus: from field to therapy.

Authors :
Kroon EG
Mota BE
Abrahão JS
da Fonseca FG
de Souza Trindade G
Source :
Antiviral research [Antiviral Res] 2011 Nov; Vol. 92 (2), pp. 150-63. Date of Electronic Publication: 2011 Aug 27.
Publication Year :
2011

Abstract

Vaccinia virus (VACV), the prototype species of the Orthopoxvirus (OPV) genus, causes an occupational zoonotic disease in Brazil that is primarily associated with the handling of infected dairy cattle. Cattle and human outbreaks have been described in southeastern Brazil since 1999 and have now occurred in almost half of the territory. Phylogenetic studies have shown high levels of polymorphisms among isolated VACVs, which indicate the existence of at least two genetically divergent clades; this has also been proven in virulence assays in a mouse model system. In humans, VACV infection is characterized by skin lesions, primarily on the hands, accompanied by systemic symptoms such as fever, myalgia, headache and lymphadenopathy. In this review, we will discuss the virological, epidemiological, ecological and clinical aspects of VACV infection, its diagnosis and compounds that potentially could be used for the treatment of severe cases.<br /> (Copyright © 2011 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-9096
Volume :
92
Issue :
2
Database :
MEDLINE
Journal :
Antiviral research
Publication Type :
Academic Journal
Accession number :
21896287
Full Text :
https://doi.org/10.1016/j.antiviral.2011.08.018